-
Published 7/16/2026
La J, Wang L, Corrigan JK, Lang D, Do NV, Brophy MT, Fillmore NR, Paller CJ. Abiraterone or Enzalutamide for Patients With Metastatic Castration-Sensitive Prostate Cancer: A Nationwide Veterans Affairs Study. JCO Clin Cancer Inform. 2026; 10(3):e2500213. PMID: 42462188.
-
Published 7/14/2026
La J, Jafari O, Nannini K, Do NV, Brophy MT, Fillmore NR, Li A. Temporal validation of the electronic health record cancer-associated thrombosis model in patients with low bleeding risk. Res Pract Thromb Haemost. 2026 Jul; 10(5):106830. PMID: 42568708.
-
Published 6/2/2026
Lam BD, Ito S, Ryu J, O'Sullivan K, Potnis K, Lu R, Bidikian A, Ng DQ, Singh R, Deter A, Carfagnini C, Bechara S, Kandula M, Do N, Fillmore N, Freed JA, Patell R, La J, Goshua G. JAKPOT Prediction Rule for Erythrocytosis: External Validation and Cost-Effectiveness Analysis. Am J Hematol. 2026 Sep; 101(9):2412-2416. PMID: 42227164.
-
Published 5/18/2026
He T, Zheng C, La J, Pham D, Jafari O, Strampe J, Dulberger K, Ramos-Cejudo J, Gaziano JM, Do NV, Chitalia V, Ravid K, Li A, Fillmore NR. A deep learning model to dynamically predict cancer-associated thromboembolism in large-scale healthcare systems. NPJ Digit Med. 2026 May 18; 9(1). PMID: 42151458.
-
Published 4/2/2026
Ryu J, La J, Patell R, Li A, Do N, Brophy M, Fillmore N, Zwicker JI. Survival assessment of warfarin and international normalized ratio exposure in cancer-associated venous thromboembolism: Veterans Affairs healthcare system-based analysis. Haematologica. 2026 Apr 02. PMID: 41924910.